Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib (original) (raw)

References

  1. Hideshima, T. et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61, 3071–3076 (2001).
    CAS PubMed Google Scholar
  2. Rock, K.L. & Goldberg, A.L. Degradation of cell proteins and the generation of MHC class I–presented peptides. Annu. Rev. Immunol. 17, 739–797 (1999).
    Article CAS Google Scholar
  3. Glickman, M.H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373–428 (2002).
    Article CAS Google Scholar
  4. Kisselev, A.F. & Goldberg, A.L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8, 739–758 (2001).
    Article CAS Google Scholar
  5. Adams, J. et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59, 2615–2622 (1999).
    CAS PubMed Google Scholar
  6. Dahlmann, B., Ruppert, T., Kloetzel, P.M. & Kuehn, L. Subtypes of 20S proteasomes from skeletal muscle. Biochimie 83, 295–299 (2001).
    Article CAS Google Scholar
  7. Driscoll, J., Brown, M.G., Finley, D. & Monaco, J.J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365, 262–264 (1993).
    Article CAS Google Scholar
  8. Gaczynska, M., Rock, K.L. & Goldberg, A.L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264–267 (1993).
    Article CAS Google Scholar
  9. Bogyo, M. et al. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl Acad. Sci. USA 94, 6629–6634 (1997).
    Article CAS Google Scholar
  10. Greenbaum, D., Medzihradszky, K.F., Burlingame, A. & Bogyo, M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7, 569–581 (2000).
    Article CAS Google Scholar
  11. Liu, Y., Patricelli, M.P. & Cravatt, B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl Acad. Sci. USA 96, 14694–14699 (1999).
    Article CAS Google Scholar
  12. Adam, G.C., Cravatt, B.F. & Sorensen, E.J. Profiling the specific reactivity of the proteome with non-directed activity-based probes. Chem. Biol. 8, 81–95 (2001).
    Article CAS Google Scholar
  13. Adam, G.C., Sorensen, E.J. & Cravatt, B.F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 20, 805–809 (2002).
    Article CAS Google Scholar
  14. Kessler, B.M. et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Chem. Biol. 8, 913–929 (2001).
    Article CAS Google Scholar
  15. Ovaa, H. et al. Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. Angew. Chem. Int. Edn. Engl. 42, 3626–3629 (2003).
    Article CAS Google Scholar
  16. Dantuma, N.P., Lindsten, K., Glas, R., Jellne, M. & Masucci, M.G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538–543 (2000).
    Article CAS Google Scholar
  17. Hideshima, T. et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61, 3071–3076 (2001).
    CAS PubMed Google Scholar
  18. Bogyo, M., Shin, S., McMaster, J.S. & Ploegh, H.L. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5, 307–320 (1998).
    Article CAS Google Scholar
  19. Garcia-Echeverria, C. Recent advances in the identification and development of 20S proteasome inhibitors. Mini Rev. Med. Chem. 2, 247–259 (2002).
    Article CAS Google Scholar
  20. Lightcap, E.S. et al. Proteasome inhibition measurements: clinical application. Clin. Chem. 46, 673–683 (2000).
    CAS PubMed Google Scholar
  21. Stein, R.L., Melandri, F. & Dick, L. Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry 35, 3899–3908 (1996).
    Article CAS Google Scholar
  22. Fiebiger, E., Story, C., Ploegh, H.L. & Tortorella, D. Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein. EMBO J. 21, 1041–1053 (2002).
    Article CAS Google Scholar
  23. Lindsten, K., Menendez-Benito, V., Masucci, M.G. & Dantuma, N.P. A transgenic mouse model of the ubiquitin/proteasome system. Nat. Biotechnol. 21, 897–902 (2003).
    Article CAS Google Scholar
  24. Luker, G.D., Pica, C.M., Song, J., Luker, K.E. & Piwnica-Worms, D. Imaging 26S proteasome activity and inhibition in living mice. Nat. Med. 9, 969–973 (2003).
    Article CAS Google Scholar
  25. Elliott, P.J., Soucy, T.A., Pien, C.S., Adams, J. & Lightcap, E.S. Assays for proteasome inhibition. Methods Mol. Med. 85, 163–172 (2003).
    CAS PubMed Google Scholar

Download references